Equillium Inc.
Organization details
- Legal name
- Equillium Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- La Jolla
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- EQ
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001746466
- EIN
- 82-1554746
Board of directors
-
Bala S. Manian · DirectorSince 2023
-
Barbara Troupin · DirectorSince 2023
-
Bruce D. Steel · Director · Chief Executive OfficerSince 2023
-
Charles Douglas McDermott · DirectorSince 2023
-
Daniel Bradbury · Director · CHAIRMANSince 2023
-
Mark Pruzanski · DirectorSince 2023
-
Martha J. Demski · DirectorSince 2023
-
Peter Colabuono · DirectorSince 2024
-
Stephen Connelly · Director · President and CSOSince 2023
-
Yu (Katherine) Xu · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
78.3%
-
99.7%
Board connections
2 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
ADMA Biologics Inc Same sectorvia Martha J. Demski
-
Alpha Teknova Inc. Same sectorvia Martha J. Demski
-
Castle Biosciences Inc. Same sectorvia Daniel Bradbury
-
Vivani Medical Inc. Same sectorvia Daniel Bradbury
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,429,490
- 18 sales by 3 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Option exercise | +14,584 | $0.79 | $11,521 |
| Jun 5, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Open-market sale | −14,584 | $2.93 | $42,731 |
| Jun 5, 2026 | Stephen Connelly Officer (President and CSO) | Open-market sale | −30,975 | $2.94 | $91,067 |
| Jun 4, 2026 | Stephen Connelly Officer (President and CSO) | Open-market sale | −200,000 | $3.16 | $632,000 |
| May 28, 2026 | Tom Penny Officer (Principal Accounting Officer) | Option exercise | +65,000 | $0.79 | $51,350 |
| May 28, 2026 | Tom Penny Officer (Principal Accounting Officer) | Open-market sale | −65,000 | $2.95 | $191,750 |
| May 28, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Option exercise | +7,292 | $0.73 | $5,323 |
| May 28, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Option exercise | +48,512 | $0.77 | $37,354 |
| May 28, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Open-market sale | −55,604 | $2.70 | $150,131 |
| May 28, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Open-market sale | −200 | $2.71 | $542 |
| May 28, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Option exercise | +14,583 | $0.79 | $11,521 |
| May 28, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Option exercise | +15,625 | $0.79 | $12,344 |
| May 28, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Open-market sale | −30,208 | $2.98 | $90,020 |
| May 27, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Option exercise | +9,821 | $0.77 | $7,562 |
| May 27, 2026 | Zedelmayer Christine Officer (Sr. Vice President and COO) | Open-market sale | −9,821 | $2.70 | $26,517 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Equillium Inc.
Who is the CEO of Equillium Inc.?
Bruce D. Steel is Equillium Inc.'s President and CEO.
How many directors are on Equillium Inc.'s board?
Equillium Inc.'s board has 10 directors: Bala S. Manian, Barbara Troupin, Bruce D. Steel, Charles Douglas McDermott, Daniel Bradbury, Mark Pruzanski, Martha J. Demski, Peter Colabuono, Stephen Connelly and Yu (Katherine) Xu.
Are Equillium Inc. insiders buying or selling shares?
Over the last 12 months, Equillium Inc. insiders made no open-market purchases and sold $2.4 million of shares in 18 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="equillium-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.